We only have this paper's title and publication details.
Read it at the sourceHigh PIV and PILE metrics are associated with lower survival in cancer patients receiving ICIs.
No takes yet. Share an insight, caveat, or question.
Kuang et al. (2024) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: